fluorodeoxyglucose f18 has been researched along with Carcinoma, Lobular in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.89) | 18.2507 |
2000's | 21 (39.62) | 29.6817 |
2010's | 26 (49.06) | 24.3611 |
2020's | 5 (9.43) | 2.80 |
Authors | Studies |
---|---|
Allen, SD; Bhaludin, BN; Downey, K; Gagliardi, T; Johnston, SRD; Koh, DM; McGrath, SE; Messiou, C; Okines, AF; Parton, MM; Pope, R; Ring, AE; Sharma, B; Tunariu, N | 1 |
Apter, S; Bernstein-Molho, R; Davidson, T; Domachevsky, L; Eifer, M; Eshet, Y; Gal-Yam, E; Globus, O; Gorfine, M; Itay, A; Levanon, K; Nissan, N; Oedegaard, C; Shapira, T; Tau, N | 1 |
Hanazaki, K; Kitagawa, H; Kobayashi, M; Maeda, H; Namikawa, T; Satake, H; Seo, S; Sugimoto, T; Tamura, M; Yokota, K | 1 |
Bellon, J; Cheng, SC; DiPiro, PJ; Hu, J; Jacene, HA; Nakhlis, F; Overmoyer, B; Rosenbluth, JM; Schlosnagle, E; Warren, L; Yeh, E | 1 |
Chae, YS; Jeong, SY; Jung, JH; Lee, IH; Lee, J; Lee, SJ; Lee, SW; Park, HY | 1 |
Hamerla, G; Meyer, HJ; Purz, S; Surov, A | 1 |
Besutti, G; Cecinato, P; Coiro, S; Di Grezia, G; Falco, G; Ferrari, G; Gatta, G; Mele, S; Vacondio, R; Zizzo, M | 1 |
Amersi, F; Chung, A; Giuliano, AE; Lee, M; Luu, M; Srour, MK; Walcott-Sapp, S | 1 |
Elkhuizen, PH; Koolen, BB; Rutgers, EJ; Valdés Olmos, RA; van der Leij, F; Vogel, WV; Vrancken Peeters, MJ | 1 |
Aliyev, A; Arslan, E; Ekmekcioglu, O; Erkan, ME; Halac, M; Kaya, R; Kocael, P; Sonmezoglu, K; Yilmaz, S | 1 |
Agresti, R; Alessi, A; Barbara, P; Bianchi, G; Bombardieri, E; Carcangiu, ML; Crippa, F; Ferraris, C; Greco, M; Maccauro, M; Martelli, G; Maugeri, I; Moscaroli, A; Pellitteri, C; Rampa, M; Sandri, M; Tagliabue, E | 1 |
Chae, BJ; Jung, NY; Kang, BJ; Kim, SH; Seo, YY; Yoo, IR | 1 |
Colletti, PM; Lisato, LC; Maffione, AM; Marzola, MC; Rasi, A; Rubello, D | 1 |
Cruz Mora, MÁ; Espinosa Aunión, R; García Vicente, AM; Gonzalez Ageitos, A; León Martín, AA; Muñoz Sánchez, Mdel M; Relea Calatayud, F; Soriano Castrejón, A; Van Gómez López, O | 1 |
Chang, HT; Chiu, YL; Hu, C; Liu, RS; Peng, NJ | 1 |
Ahn, SG; Dong, SM; Han, K; Jeon, TJ; Jeong, J; Lee, HM; Lee, HW; Lee, SA; Park, JT; Ryu, YH; Son, EJ | 1 |
Choi, BB; Jung, NY; Kim, SH; Sung, MS | 1 |
Ailianou, A; Giger, R; Karamitopoulou, E; Landis, BN; Nisa, L; Salmina, C | 1 |
Chisin, R; Freedman, N; Klein, M; Orevi, M; Peretz, T; Tahover, E; Uziely, B | 1 |
Dashevsky, B; Goldman, DA; Gönen, M; Hogan, MP; Hudis, C; Jochelson, M; Morrow, M; Osborne, JR; Riedl, CC; Ulaner, GA | 1 |
Fujimoto, Y; Fukushima, K; Higuchi, T; Imamura, M; Kitajima, K; Miyagawa, Y; Miyoshi, Y; Murase, K; Nishimukai, A; Ozawa, H; Takatsuka, Y; Yanai, A | 1 |
Fujii, T; Higuchi, T; Horiguchi, J; Kurozumi, S; Kuwano, H; Nagaoka, R; Obayashi, S; Takata, D; Tokiniwa, H; Yajima, R | 1 |
Elkhuizen, PH; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Stokkel, MP; Teixeira, SC; Valdés Olmos, RA; van der Noort, V; Vrancken Peeters, MT | 1 |
Inoue, T; Ishikawa, T; Kaneta, T; Narui, K; Noritake, M; Sakamaki, K; Sugae, S | 1 |
Kasami, M; Uematsu, T; Yuen, S | 1 |
El-Kholy, MR; El-Shorbagy, E; Murakami, K; Zytoon, AA | 1 |
Beorlegui, C; García-Velloso, MJ; Gil-Rendo, A; Martínez-Regueira, F; Rodriguez-Spiteri, N; Zornoza, G | 1 |
Fox, J; Ganju, V; Hart, S; Hofman, M; Midolo, P; Schneider-Kolsky, ME; Stuckey, J | 1 |
Aukema, TS; Gilhuijs, KG; Olmos, RA; Peeters, MJ; Russell, NS; Rutgers, EJ; Straver, ME; Vogel, WV | 1 |
Bouteille, C; Cimarelli, S; Heudel, P; Mognetti, T; Montella, A | 1 |
Bluemke, DA; Gabrielson, E; Jacobs, MA; Jeter, S; Ouwerkerk, R; Stearns, V; Wahl, R; Warzecha, H; Wolff, AC | 1 |
Lindskog, DM; Nikkhou, K; Talusan, P | 1 |
Andersson, M; Bernsdorf, M; Berthelsen, AK; Binderup, T; Graff, J; Kjær, A; Kroman, N; Loft, A; Tange, UB; Teilum, D; Wielenga, VT | 1 |
de Bazelaire, C; de Roquancourt, A; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Merlet, P; Toubert, ME; Vercellino, L | 1 |
Bachmann, S; Berger, J; Bleckmann, C; Bohuslavizki, KH; Dose, J; Habermann, CR; Jãnicke, F; Jenicke, L | 1 |
Buck, A; Dankerl, A; Glatting, G; Kalker, T; Kotzerke, J; Kühn, T; Mattfeldt, T; Reske, S; Schirrmeister, H; Shen, C | 1 |
Garcia, CA; Rosenberg, RJ; Spencer, RP | 1 |
Fehr, MK; Goerres, GW; Kamel, EM; von Schulthess, GK; Wyss, MT | 1 |
Boom, RP; Buter, J; Comans, EF; Hoekstra, OS; Krak, NC; Lammertsma, AA; Meijer, S; Pinedo, HM; Teule, GJ; van der Hoeven, JJ; van der Wall, E; van Geldere, D | 1 |
Harling, H; Laoutliev, B; Neergaard, K; Simonsen, L | 1 |
Alavi, A; Kumar, R | 1 |
Baker, JA; Coleman, RE; Rosen, EL; Soo, MS; Turkington, TG | 1 |
Ampil, F; Burton, G; Chu, QD; Johnson, LW; Li, BD; Lilien, D; Turnage, RH; Wolfort, RM | 1 |
Chung, A; Fujimoto, K; Hagiike, M; Karlan, S; Liou, D; Phillips, EH; Waxman, A | 1 |
Baird, GS; Kanne, JP; Livingston, RB; Mankoff, DA; Minoshima, S | 1 |
Chen, JH; Li, D; Ling, R; Wang, J; Wang, L; Yao, Q | 1 |
Cristofanilli, M; Dawood, S; Gamez, C; Macapinlac, HA; Tateishi, U; Yeung, HW | 1 |
Abe, Y; Asakawa, H; Fukatsu, K; Hama, Y; Ishida, J; Kondo, N; Mochizuki, H; Shigekawa, T; Tamura, K; Tsuda, H; Ueda, S; Yamamoto, M | 1 |
Kusuoka, H; Nishimura, T; Shiba, E; Tatsumi, M; Yutani, K | 1 |
Avril, N; Dose, J; Graeff, H; Jänicke, F; Kuhn, W; Nährig, J; Römer, W; Sattler, D; Schelling, M; Schwaiger, M; Werner, M | 1 |
Avril, N; Bense, S; Dose, J; Graeff, H; Kuhn, W; Rosé, CA; Schelling, M; Schwaiger, M; Weber, W; Ziegler, S | 1 |
Avril, N; Dose, J; Jänicke, F; Menzel, M; Nathrath, W; Schelling, M; Schwaiger, M; Weber, W | 1 |
Brown, RS; Goodman, TM; Greenson, JK; Wahl, RL; Zasadny, KR | 1 |
3 review(s) available for fluorodeoxyglucose f18 and Carcinoma, Lobular
Article | Year |
---|---|
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Whole Body Imaging | 2022 |
Warthin's tumor of the larynx: a very rare case and systematic review of the literature.
Topics: Adenolymphoma; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngoscopy; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Fluorodeoxyglucose-PET in the management of breast cancer.
Topics: Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2004 |
6 trial(s) available for fluorodeoxyglucose f18 and Carcinoma, Lobular
Article | Year |
---|---|
Is (18)F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Taxoids; Treatment Outcome | 2010 |
Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiography; Radiopharmaceuticals; Sodium Isotopes; Taxoids; Treatment Outcome | 2011 |
FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Topics: Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Reproducibility of Results; Statistics as Topic; Tissue Distribution; Tomography, Emission-Computed | 2002 |
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
Topics: Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Expression of hexokinase II and Glut-1 in untreated human breast cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Excitatory Amino Acid Transporter 2; Fluorodeoxyglucose F18; Hexokinase; Humans; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method | 2002 |
44 other study(ies) available for fluorodeoxyglucose f18 and Carcinoma, Lobular
Article | Year |
---|---|
The Role of 68 Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer.
Topics: Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
Gastric and Bone Metastases Arising from Invasive Lobular Carcinoma With Ductal Carcinoma Occurring in one Breast Synchronously.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Stomach | 2023 |
Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning.
Topics: Adult; Aged; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammatory Breast Neoplasms; Middle Aged; Neoplasm Staging; Patient Care Planning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Utility of
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate | 2020 |
Topics: Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Esophageal Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Ultrasonography, Mammary | 2018 |
Colonic metastasis from breast carcinoma detection by CESM and PET/CT: A case report.
Topics: Aged; Asymptomatic Diseases; Breast; Breast Neoplasms; Carcinoma, Lobular; Colectomy; Colon; Colonic Neoplasms; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Mammography; Mucin-1; Neoplasm Invasiveness; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Receptors, Cell Surface; Treatment Outcome | 2018 |
Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Medical Overuse; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen | 2019 |
Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2013 |
Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphoscintigraphy; Middle Aged; Neoplasm Staging; Organotechnetium Compounds; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Young Adult | 2014 |
Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary; Young Adult | 2016 |
Lobular breast carcinoma: a case of rare possible 18F-FDG PET/CT and bone scan false negative.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma, Lobular; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Glycolytic activity with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2014 |
Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; ErbB Receptors; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone and Bones; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies | 2015 |
Prognostic significance of preoperative
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gonadotropin-Releasing Hormone; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tamoxifen; Tumor Burden | 2016 |
Clinical Significance of 18F-FDG-PET in Invasive Lobular Carcinoma.
Topics: Aged; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2016 |
PET/CT with
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Trastuzumab; Young Adult | 2017 |
Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Taxoids; Trastuzumab; Treatment Outcome; Whole Body Imaging | 2017 |
Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Statistics, Nonparametric; Young Adult | 2009 |
Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Topics: Adult; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2010 |
Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
False-positive positron emission tomography in patients with history of malignancy.
Topics: Adult; Anus Neoplasms; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma, Lobular; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Preoperative PET/CT in early-stage breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.
Topics: Adult; Aged; Analysis of Variance; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Contrast Media; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2012 |
Comparison of fluorodeoxyglucose positron emission tomography and "conventional diagnostic procedures" for the detection of distant metastases in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2002 |
FDG-positron emission tomographic imaging in carcinoma of the breast: interference by massive sarcoidosis.
Topics: Adult; Breast Neoplasms; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sarcoidosis; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
[18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Rectal metastasis from infiltrating lobular breast carcinoma: imaging with 18F-FDG PET.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2005 |
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Breast Diseases; Breast Neoplasms; Calcinosis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2005 |
The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Preoperative FDG-PET for axillary metastases in patients with breast cancer.
Topics: Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2006 |
Gastric linitis plastica from metastatic breast carcinoma: FDG and FES PET appearances.
Topics: Aged; Breast Neoplasms; Carcinoma, Lobular; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Linitis Plastica; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
[Value of fused 18F-FDG PET/CT images in predicting efficacy of neoadjuvant chemotherapy on breast cancer].
Topics: Adult; Aged; Apoptosis; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; In Situ Nick-End Labeling; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2008 |
Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Middle Aged; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
Topics: Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunohistochemistry; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |